Fig. 1From: Current concepts in the diagnosis and management of antiphospholipid syndrome and ocular manifestationsEndothelial cell activation and mechanism action of potential future therapeutics in antiphospholipid syndrome [12]. β2GPI: β2 glycoprotein-I; TLR: toll-like receptor; TF: tissue factor; eNOS: endothelial nitric oxide synthase; mTOR: mammalian target of rapamycin; ROS: reactive oxygen species; NFκB: nuclear factor kappa-light-chain-enhancer of B cellsBack to article page